MemScan is developing a diagnostic method that combines artificial intelligence, fractal analysis, and electroretinography, using a proprietary algorithm, artificial intelligence (AI) and Machine Learning (ML) for the purposes of accurately diagnosing cognitive impairment as early as possible. The technology suite was developed by a clinical team based at the University of Miami Miller School of Medicine and the Bascom Palmer Eye Institute, one of the world’s top eye and vision research centers.

In the News

MemScan in the News

Ikove and its portfolio of companies are making noise with groundbreaking innovation.

No items found.
Subscribe for our News & Insights
Join our newsletter to stay up to date on features and releases.
By subscribing you agree to with our Privacy Policy and provide consent to receive updates from our company.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Ikove makes no warranties, express or implied, regarding any of the information on this website. None of the information on this website is investment advice. This website is not a solicitation of investment or offer to purchase or sell securities.